Cancer Biological Therapy Market: Top Players – F. Hoffmann-La Roche, GlaxoSmithKline, Incyte, Merck, Novartis, Otsuka, Pfizer, Sanofi, Seattle Genetics, Amgen, Astellas
Cancer Biological Therapy Market size is set to exceed USD 108 billion by 2024; according to a new research report by Global Market Insights. Increasing burden of cancer in developed as well as developing countries is major factor that will drive cancer biological therapy market growth. Cancer is one of the leading causes of mortality and morbidity across the globe. According to the World Health Organization in 2018, cancer accounted for around 18.1 million new cases worldwide. Moreover, rapidly ageing...
View full press release